Floatz logo

Therapeutic Asset Ratings

178 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Avelumab
Ureter Cancer
Emory UniversityP2CCC (48)
Avelumab
Urethra Cancer
Emory UniversityP2CCC (48)
Baricitinib
Major Depressive Disorder
Emory UniversityP2CCC (48)
Cyclophosphamide
Major Depressive Disorder
Emory UniversityP2CCC (48)
Dfn-15
Cancer
Emory UniversityP2CCC (48)
BMS-986345
Recurrent Diffuse Large B-Cell Lymphoma
Emory UniversityP1CCC (48)
Duvelisib
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Emory UniversityP1CCC (48)
TIPIRACIL
Cholangiocarcinoma
Emory UniversityP1/2CCC (48)
TIPIRACIL
Stage III Gastric Cancer
Emory UniversityP1/2CCC (48)
TIPIRACIL
Stage III Pancreatic Cancer
Emory UniversityP1/2CCC (48)
TIPIRACIL
Gastric Cancer
Emory UniversityP1/2CCC (48)
TIPIRACIL
Malignant Pancreatic Neoplasm
Emory UniversityP1/2CCC (48)
TIPIRACIL
Digestive System Carcinoma
Emory UniversityP1/2CCC (48)
TIPIRACIL
Exocrine Pancreatic Carcinoma
Emory UniversityP1/2CCC (48)
Trifluridine
Cholangiocarcinoma
Emory UniversityP1/2CCC (48)
Trifluridine
Stage III Gastric Cancer
Emory UniversityP1/2CCC (48)
Trifluridine
Stage III Pancreatic Cancer
Emory UniversityP1/2CCC (48)
Trifluridine
Gastric Cancer
Emory UniversityP1/2CCC (48)
Trifluridine
Malignant Pancreatic Neoplasm
Emory UniversityP1/2CCC (48)
Trifluridine
Digestive System Carcinoma
Emory UniversityP1/2CCC (48)
Trifluridine
Exocrine Pancreatic Carcinoma
Emory UniversityP1/2CCC (48)
Dfn-15
Neoplasm
Emory UniversityP2CC (46)
Vedolizumab
Major Depressive Disorder
Emory UniversityP2CC (46)
TEONANACATL
Hematopoietic And Lymphoid Cell Neoplasm
Emory UniversityP1CC (46)
Vidutolimod
Metastatic Prostate Adenocarcinoma
Emory UniversityP2CC (45)
Showing 126 to 150 of 178 assets
PreviousPage 6 of 8Next